Delivery Order SPE2DR25D1017-SPE2DR26F8ZHS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $29,770.38 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) on September 19, 2025, with completion scheduled for September 22, 2025. This delivery order was issued as a firm fixed price contract with no set-aside designation, utilizing open competition. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $3,549.93 delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count unit dose packaging) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery location is specified as Conshohocken, PA, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,369.69 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This contract, issued on August 27, 2025, with completion targeted for August 28, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating open competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,969.84 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 12, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $4,070.31 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit-dose packaging (30-count), with an ultimate completion date of September 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $2,724.06. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,021.48 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract requires performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,162.68 delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count) on November 10, 2025, with completion targeted for November 12, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $4,513.88. This competitively awarded, firm fixed-price delivery order was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count) valued at $4,197.60. The contract was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents a competitive award to AmerisourceBergen's corporate office, with the place of performance located in Conshohocken,...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8ZHSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,258.85 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). The contract, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills routine medication needs across the Defense Health System through this flexible contracting mechanism, which allows for efficient procurement of essential medications including antihypertensive agents like the telmisartan-hydrochlorothiazide combination awarded in this instance.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/10/25 |